NeD (Next Dimension) is developing the next generation of retinal imaging systems, which utilize spectral imaging to map metabolic activity in the retina that can provide an early warning prior to the onset of noticeable anatomic tissue damage followed by vision loss.The system will be used as part of the routine practice to diagnose and monitor the treatment of patients suffering from vision threatening diseases such as Diabetic Retinopathy, AMD and Glaucoma.